Brandon M. Fox

Brandon M. Fox

Auto-generated profile, based on publicly available information

Brandon M. Fox

Cardio-Renal Physiology and Medicine, Department of Medicine, and

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 March 2017 in Journal of the American Society of Nephrology
Verified
Journal Article
Open access
PDF file
MKMalgorzata Kasztan
Malgorzata Kasztan
BFBrandon M. Fox
Brandon M. Fox
JSJoshua S. Speed
Joshua S. Speed
CMCarmen De Miguel
Carmen De Miguel
EGEman Y. Gohar
Eman Y. Gohar
DPDavid M. Pollock
David M. Pollock
Sickle cell disease (SCD)–associated nephropathy is a major source of morbidity and mortality in patients because of the lack of efficacious treatments targeting renal manifestations of the disease. Here, we describe a long-term treatment strategy with the selective endothelin-A receptor (ETA) antagonist, ambrisentan, designed to interfere with the development of nephropathy in a humanized mouse model of SCD. Ambrisentan preserved GFR at the level of nondisease controls and prevented the development of proteinuria, albuminuria, and nephrinuria. Microscopy studies demonstrated prevention of podocyte loss and structural alterations, the absence of vascular congestion, and attenuation of glomerulosclerosis in treated mice. Studies in isolated glomeruli showed that treatment reduced inflammation and oxidative stress. At the level of renal tubules, ambrisentan treatment prevented the increased excretion of urinary tubular injury biomarkers. Additionally, the treatment strategy prevented tubular brush border loss, diminished tubular iron deposition, blocked the development of interstitial fibrosis, and prevented immune cell infiltration. Furthermore, the prevention of albuminuria in treated mice was associated with preservation of cortical megalin expression. In a separate series of identical experiments, combined ETA and ETB receptor antagonism provided only some of the protection observed with ambrisentan, highlighting the importance of exclusively targeting the ETA receptor in SCD. Our results demonstrate that ambrisentan treatment provides robust protection from diverse renal pathologies in SCD mice, and suggest that long-term ETA receptor antagonism may provide a strategy for the prevention of renal complications of SCD.

9 July 2019 in Oncogene
Verified
Journal Article
Closed access
PDF file
STStacie K. Totsch
Stacie K. Totsch
CSCharles Schlappi
Charles Schlappi
KKKyung-Don Kang
Kyung-Don Kang
AIAndrew S. Ishizuka
Andrew S. Ishizuka
GLGeoffrey M. Lynn
Geoffrey M. Lynn
GFGregory Friedman
Gregory Friedman

1 January 2018 in American Journal of Physiology-Renal Physiology
Verified
Journal Article
Closed access
PDF file
JSJoshua S. Speed
Joshua S. Speed
KHKelly A. Hyndman
Kelly A. Hyndman
KRKaehler Roth
Kaehler Roth
JHJonathan B. Heimlich
Jonathan B. Heimlich
MKMalgorzata Kasztan
Malgorzata Kasztan
DPDavid M. Pollock
David M. Pollock
Dyssynchrony of circadian rhythms is associated with various disorders, including cardiovascular and metabolic diseases. The cell autonomous molecular clock maintains circadian control; however, environmental factors that may cause circadian dyssynchrony either within or between organ systems are poorly understood. Our laboratory recently reported that the endothelin (ET-1) B (ETB) receptor functions to facilitate Na+excretion in a time of day-dependent manner. Therefore, the present study was designed to determine whether high salt (HS) intake leads to circadian dyssynchrony within the kidney and whether the renal endothelin system contributes to control of the renal molecular clock. We observed that HS feeding led to region-specific alterations in circadian clock components within the kidney. For instance, HS caused a significant 5.5-h phase delay in the peak expression of Bmal1 and suppressed Cry1 and Per2 expression in the renal inner medulla, but not the renal cortex, of control rats. The phase delay in Bmal1 expression appears to be mediated by ET-1 because this phenomenon was not observed in the ETB-deficient rat. In cultured inner medullary collecting duct cells, ET-1 suppressed Bmal1 mRNA expression. Furthermore, Bmal1 knockdown in these cells reduced epithelial Na+channel expression. These data reveal that HS feeding leads to intrarenal circadian dyssynchrony mediated, in part, through activation of ETBreceptors within the renal inner medulla.

7 May 2019 in Blood Advances
Verified
Journal Article
Closed access
PDF file
MKMalgorzata Kasztan
Malgorzata Kasztan
BFBrandon M. Fox
Brandon M. Fox
JLJeffrey D. Lebensburger
Jeffrey D. Lebensburger
KHKelly A. Hyndman
Kelly A. Hyndman
JSJoshua S. Speed
Joshua S. Speed
DPDavid M. Pollock
David M. Pollock
Key Points: In HbSS mice, hyperfiltration predicts long-term kidney damage and tubular injury occurs prior to glomerular damage. Sex contributes to the progression of kidney injury in HbSS mice.

1 March 2015 in Seminars in Nephrology
Verified
Journal Article
Closed access
JSJoshua S. Speed
Joshua S. Speed
BFBrandon M. Fox
Brandon M. Fox
JJJermaine G. Johnston
Jermaine G. Johnston
DPDavid M. Pollock
David M. Pollock

28 August 2014 in Physiological Reports
Verified
Journal Article
Open access
PDF file
ALAnalia S. Loria
Analia S. Loria
KBKrystal N. Brinson
Krystal N. Brinson
BFBrandon M. Fox
Brandon M. Fox
JSJennifer C. Sullivan
Jennifer C. Sullivan
The present study tested the hypothesis that spontaneously hypertensive rats (SHR) have impaired nitric oxide synthase (NOS)-mediated regulation of vascular function versus Wistar-Kyoto rats (WKY). Aorta and small mesenteric arteries were studied from male and female SHR (M SHR and F SHR) and WKY (M WKY and F WKY). Phenylephrine (PE)-induced vasoconstriction was greater in aorta of M SHR versus all others (P < 0.05); there were neither sex nor strain differences in PE contraction in mesenteric arteries. The NOS inhibitor l-Nitro-Arginine Methyl Ester (l-NAME) increased PE-induced vasoconstriction in all rats, although the increase was the least in male SHR (P < 0.05), revealing a blunted vasoconstrictor buffering capacity of NOS. l-NAME increased sensitivity to PE-induced constriction only in mesenteric arteries of SHR, although, the maximal percent increase in contraction was comparable among groups. ACh-induced relaxation was also less in aorta from M SHR versus all others (P < 0.05). ACh relaxation was comparable among groups in mesenteric arteries, although SHR exhibited a greater NOS component to ACh-induced relaxation than WKY. To gain mechanistic insight into sex and strain differences in vascular function, NOS activity and NOS3 protein expression were measured. Aortic NOS activity was comparable between groups and M SHR had greater NOS3 expression than M WKY. In contrast, although vascular function was largely maintained in mesenteric arteries of SHR, NOS activity was less in SHR versus WKY. In conclusion, M SHR exhibit a decrease in NOS regulation of vascular function compared to F SHR and WKY, although this is not mediated by decreases in NOS activity and/or expression.